ID   NP-2/APJ
AC   CVCL_1R19
DR   cancercelllines; CVCL_1R19
DR   Wikidata; Q54930941
RX   PubMed=11112502;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:339; APLNR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1R15 ! NP-2
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 12
//
RX   PubMed=11112502; DOI=10.1006/viro.2000.0623;
RA   Liu, Hui-Yu
RA   Soda, Yasushi
RA   Shimizu, Nobuaki
RA   Haraguchi, Yuji
RA   Jinno-Oue, Atsushi
RA   Takeuchi, Yasuhiro
RA   Hoshino, Hiroo
RT   "CD4-dependent and CD4-independent utilization of coreceptors by human
RT   immunodeficiency viruses type 2 and simian immunodeficiency viruses.";
RL   Virology 278:276-288(2000).
//